May 2022

Features

Look But Don't Touch

Musings on life, ophthalmology and the practice of medicine.

Outfitting Your Practice for the Future

Of all the pandemic-induced changes, which will become part of the new normal’s modus operandi?

Gene Therapy for Inherited Retinal Disease

A look at the results ophthalmic researchers and companies are generating as they explore genetic therapies for these difficult-to-treat conditions.

The Best Approach for Narrow-Angle Patients

The age of the patient is one of the many factors to consider when treating patients with narrow angles, experts say.

The Glaucoma Medication Pipeline, 2022

Catching up on the status of four eye drops being developed to target the disease.

Update: Private Equity in Ophthalmology

Many surgeons say they’ve had a positive experience—but proceeding with caution is advised.

Departments

Review News

Vision Loss Study Breaks Down National Cost Burden

Editor's Page

Spring Forward

Technology Update

Promising New Ways to Monitor Glaucoma

New technologies are showing promise for more accurate monitoring—and predicting of—progression.

Medicare Q & A

Post-pandemic, Whither Telemedicine?

When the official public health emergency eventually ends, will telemedicine maintain its level of prominence?

Retinal Insider

The Gut Microbiome’s Impact on the Retina

The gut microbiome is being shown to have effects on many disease states, and retinal disease is no exception.

Glaucoma Management

Prostaglandins and IOP: What's Really Going On?

Evidence suggests that these drugs cause a long-term IOP reduction in some patients. Here's the latest.

Product News

IOP Measurement Comes Home

Product News: New offerings to help improve clinical care and strengthen your practice.

Wills Eye Resident Case Series

May 2022 Wills Eye Resident Case Series

An 18-year-old male has to contend with a very high refractive error.

Current Issue